Morgan Stanley downgraded Melexis (MLXSF) to Equal Weight from Overweight with a price target of EUR 55, down from EUR 80. The company’s fiscal 2026 outlook breaks the narrative of a growth and margin recovery, the analyst tells investors in a research note.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MLXSF: